Literature DB >> 22786905

A novel technique of adjusting segmentation boundary layers to achieve comparability of retinal thickness and volumes between spectral domain and time domain optical coherence tomography.

Colin S H Tan1, Kelvin Z Li, Tock Han Lim.   

Abstract

PURPOSE: The quantitative assessment of retinal thickness and volume varies according to the optical coherence tomography (OCT) machine used due to differences in segmentation lines. We describe a novel method of adjusting the segmentation lines of spectral-domain OCT (SD-OCT) to enable comparison with time-domain OCT (TD-OCT), and assess factors affecting its accuracy.
METHODS: In a prospective study, SD-OCT (Spectralis OCT) and TD-OCT (Stratus OCT) were sequentially performed on 200 eyes of 100 healthy individuals. Central retinal thickness (CRT), central point thickness (CPT), and 1-mm volume of the Early Treatment Diabetic Retinopathy Study grid were compared between the two machines. The segmentation lines on SD-OCT were manually adjusted by a trained operator and the parameters compared again with TD-OCT.
RESULTS: The mean CRTs of Spectralis and Stratus were significantly different (268.2 μm vs. 193.9 μm, P < 0.001). After adjustment of segmentation lines, the mean adjusted Spectralis CRT was 197.3 μm, with the difference between SD-OCT and TD-OCT measurements decreasing from 74.3 μm to 3.4 μm (P < 0.001). The difference between the adjusted Spectralis and Stratus CRTs was smallest for high myopes (≤ -6.0 diopters [D]) compared with those with moderate and low myopia (1.5 μm vs. 3.5 μm and 4.6 μm, respectively; P < 0.001). Similar trends were obtained for central 1-mm volumes and CPT. Interoperator and intraoperator repeatability for adjustment of the segmentation lines were good, with an intraclass correlation of 0.99 for both.
CONCLUSIONS: Manual adjustment of SD-OCT segmentation lines reliably achieves retinal thickness and volume measurements that are comparable to that of TD-OCT. This is valuable to allow comparisons in multicenter clinical trials where different OCT machines may be used.

Entities:  

Mesh:

Year:  2012        PMID: 22786905     DOI: 10.1167/iovs.12-9868

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Letter to the editor: Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization.

Authors:  Milton C Chew; Colin S Tan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-16       Impact factor: 3.117

2.  Comparability of retinal thickness measurements using different scanning protocols on spectral-domain optical coherence tomography.

Authors:  Milton C Chew; Louis W Lim; Eujin Tan; Colin S Tan
Journal:  Int Ophthalmol       Date:  2016-02-18       Impact factor: 2.031

3.  Overestimation of subfoveal choroidal thickness by measurement based on horizontally compressed optical coherence tomography images.

Authors:  Colin S H Tan; Kai Xiong Cheong; SriniVas R Sadda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-09-22       Impact factor: 3.117

4.  Calculating the predicted retinal thickness from spectral domain and time domain optical coherence tomography - comparison of different methods.

Authors:  Colin S Tan; Kelvin Z Li; Tock Han Lim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-27       Impact factor: 3.117

Review 5.  The role of central reading centers--current practices and future directions.

Authors:  Colin S Tan; Srinivas R Sadda
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

6.  Repeatability of Foveal Measurements Using Spectralis Optical Coherence Tomography Segmentation Software.

Authors:  Irene Ctori; Byki Huntjens
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

7.  SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A RANDOMIZED CONTROLLED CROSSOVER STUDY.

Authors:  Elodie Bousquet; Talal Beydoun; Pierre-Raphaël Rothschild; Ciara Bergin; Min Zhao; Rui Batista; Marie-Laure Brandely; Benedicte Couraud; Nicolette Farman; Alain Gaudric; François Chast; Francine Behar-Cohen
Journal:  Retina       Date:  2015-12       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.